| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |